Summary
Aminophylline reversed the protective action of both, D-3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid (D-CPP-ene — a competitive NMDA antagonist) and valproate (used as a conventional antiepileptic drug for comparative purposes) against maximal electroshock-induced seizures. The respective ED50 values of aminophylline were 55.7 and 98.4mg/kg i.p. However, aminophylline (up to 100mg/kg i.p.) did not influence the protective efficacy of 1-(4-aminophenyl)-4-methyl-7,8-methyl-enedioxy-5H-2, 3-benzodiazepine (GYKI 52466 — a non-NMDA antagonist). Strychnine affected the protection provided by D-CPP-ene, GYKI 52466, and valproate against maximal electroshock — the ED50 values of strychnine for the reversal of the anticonvulsive effects of D-CPP-ene, GYKI 52466 or valproate were 0.082, 0.35 and 0.28mg/kg s.c., respectively.
An involvement of strychnine sensitive glycinergic receptor-mediated events in the mechanism of the anticonvulsive activity of excitatory amino acid antagonists and valproate may be postulated. The ineffectiveness of aminophylline to reduce the anticonvulsive effects of GYKI 52466 may distinguish a new class of antiepileptic drugs offering an advantage over conventional antiepileptics in patients with epilepsy, requiring aminophylline for pulmonary reasons.
Similar content being viewed by others
References
Aebischer B, Frey P, Haerter HP, Herrling PL, Mueller W, Olverman HJ, Watkins JC (1989) Synthesis and NMDA antagonistic properties of the enantiomers of 4-3-phosphonopropyl-piperazine-2-carboxylic acid (CPP) and of the unsaturated analogue (E-4-(3-phosphonoprop-2-enyl)-piperazine-2-carboxylic acid (CPP-ene). Helv Chim Acta 72: 1043–1051
Borowicz KK, Kozicka M, Kleinrok Z, Czuczwar SJ (1993) Influence of aminophylline and 8-(p-sulfophenyl)theophylline on the anticonvulsive action of diphenyl-hydantoin, phenobarbital, and valproate against maximal electroshock-induced convulsions in mice. J Neural Transm [Gen Sect] 93: 157–163
Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ (1995) The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol 281: 319–326
Chu N-S (1981) Caffeine- and aminophylline-induced seizures. Epilepsia 22: 85–94
Czuczwar SJ, Turski WA, Ikonomidou C, Turski L (1985) Aminophylline and CGS 8216 reverse the protective action of diazepam against electroconvulsions in mice. Epilepsia 26: 693–696
Czuczwar SJ, Ikonomidou C, Kleinrok Z, Turski L, Turski WA (1986) Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 27: 204–208
Czuczwar SJ, Jäckel R, Löscher W (1987a) Effects of aminophylline and enprofylline on the protective activity of phenobarbital against amygdala-kindled seizures in rats. Epilepsy Res 1: 234–238
Czuczwar SJ, Kleinrok Z, Turski L, Turski WA (1987b) Effect of aminophylline and enprofylline upon the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 28: 383–386
Czuczwar SJ, Janusz W, Szczepanik B, Wamil A, Kleinrok Z (1989) Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci Res 6: 470–474
Czuczwar SJ, Włodarczyk D, Gasior M, Kleinrok Z (1991) Is there a glycinergic component in the mechanisms of action of common antiepileptic drugs? In: Klee MR, Lux HD, Speckmann EJ (eds) Physiology, pharmacology and development of epileptogenic phenomena. Springer, Berlin Heidelberg New York Tokyo, pp 255–257
Czuczwar SJ, Gasior M, Turski WA, Kleinrok Z (1994) Influence of a Ca2+ channel agonist, BAY k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists. Eur J Pharmacol 264: 103–106
Donevan SD, Rogawski MA (1993) GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA-/kainate receptor responses. Neuron 10: 51–59
Jensen MH, Jorgensen S, Nielsen H, Sanchez R, Andersen PK (1985) Is theophylline induced seizure in man caused by inhibition of cerebral 5′-nucleotidase activity? Acta Pharmacol Toxicol 55: 331–334
Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–113
Löscher W, Hönack D (1991) Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther 256: 432–440
Meldrum B (1992) Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res 12: 189–197
Neering IR, McBurney RN (1984) Role for microsomal Ca storage in mammalian neurons? Nature 309: 158–160
Rogawski MA (1992) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14: 325–331
Smith SE, Durmuller N, Meldrum B (1991) The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol 201: 179–183
Tarnawa I, Engberg I, Flatman JA (1990) GYKI 52466, an inhibitor of spinal reflexes is a potent quisqualate antagonist. In: Lubec G, Rosenthal GA (eds) Amino acids: chemistry, biology and medicine. Escom, Leiden, pp 538–546
Toth E, Lajtha A, Sarhan S, Seiler N (1983) Anticonvulsant effects of some inhibitory neurotransmitter amino acids. Neurochem Res 8: 291–302
Tutka P, Turski WA, Czuczwar SJ, Kleinrok Z (1992) Anticonvulsant activity of the competitive NMDA antagonist D-CPPene and magnesium valproate in mice — a comparison. Pol J Pharmacol Pharm 44: 239
Wlaź P, Roliński Z, Kleinrok Z, Czuczwar SJ (1992) Anticonvulsant activity of carbamazepine and diphenylhydantoin against maximal electroshock in mice chronically treated with aminophylline. J Neural Transm [Gen Sect] 89: 41–48
Wlaz P, Rolinski Z, Kleinrok Z, Czuczwar SJ (1993) Influence of chronic aminophylline on the anticonvulsant efficacy of phenobarbital and valproate in mice. Epilepsia 34: 385–389
Yamaguchi S, Donevan SD, Rogawski MA (1993) Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant models. Epilepsy Res 15: 179–184
Yarnell PR, Chu NS (1975) Focal seizures and aminophylline. Neurology 25: 819–822
Zwillich CW, Sutton FD, Neff TA, Cohn WM, Matthay RA, Weinberger MM (1975) Theophylline-induced seizures in adults. Ann Intern Med 82: 784–787
Zarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ (1994) The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice. Neuropharmacology 33: 619–624
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tutka, P., Turski, W.A., Kleinrok, Z. et al. Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice. J. Neural Transmission 103, 307–314 (1996). https://doi.org/10.1007/BF01271242
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01271242